![AstraZeneca PLC](/common/images/company/NY_AZN.png)
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 4.768 | 3.476 | 2.188 | 4.99 | 0.13 | 3.258 | 6.027 | 6.858 |
Return on Equity (%) | 18.018 | 14.045 | 9.323 | 21.142 | 0.408 | 8.614 | 15.625 | 17.579 |
Return on Invested Capital (%) | 18.558 | 14.115 | 12.788 | 22.441 | 22.805 | 9.424 | 20.809 | 15.647 |
Operating Margin (%) | 15.967 | 15.215 | 12.098 | 19.491 | 2.713 | 8.638 | 18.535 | 19.294 |
Net Profit Margin (%) | 13.359 | 9.756 | 5.475 | 12.007 | 0.299 | 7.414 | 12.999 | 13.01 |
Book Value Per Share | -16.878 | -15.487 | -13.646 | -13.068 | -14.907 | -14.24 | -12.238 | N/A |
Earnings Per Share | 2.37 | 1.701 | 1.017 | 2.435 | 0.072 | 2.122 | 3.842 | N/A |
Cash Per Share | 2.625 | 3.813 | 4.092 | 5.966 | 4.085 | 3.979 | 3.767 | N/A |
Working Capital Per Share | -2.553 | -0.553 | -1.946 | -0.581 | 2.356 | -2.387 | -3.54 | N/A |
Operating Profit Per Share | 15.272 | 17.09 | 18.032 | 19.052 | 20.67 | 21.674 | 25.686 | N/A |
EBIT Per Share | 1.759 | 1.573 | 1.18 | 2.983 | -0.171 | 1.614 | 4.45 | N/A |
EBITDA Per Share | 1.759 | 1.573 | 1.18 | 2.983 | -0.171 | 1.614 | 4.45 | N/A |
Free Cash Flow Per Share | 4.51 | 3.383 | 3.5 | 5.008 | 1.35 | 3.285 | 5.99 | N/A |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 1.27B | 1.27B | 1.31B | 1.31B | 1.55B | 1.55B | 1.55B | N/A |
Year End December 30 2024 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 1.55B | N/A | N/A | N/A | 1.55B | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 24.147 | N/A | N/A | N/A | 25.341 | N/A | N/A |
Net Profit Margin (%) | N/A | 16.573 | N/A | N/A | N/A | 17.186 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 83.97B |
Price to Earnings Ratio | 25.68 |
Price to Sales Ratio | 3.34 |
Price to Cash Ratio | 32.91 |
Price to Book Ratio | 4.42 |
Dividend Yield | - |
Shares Outstanding | 1.55B |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.